Medical & Reimbursement Policies
Medication Policies
- ALPHA 1 PROTEINASE INHIBITORS
- AMVUTTRA
- BOTULINUM TOXINS
- CHIMERIC ANTIGEN RECEPTOR T CELL (CAR-T) IMMUNOTHERAPY
- CYTOKINE AND CAM
- DUCHENNE MUSCULAR DYSTROPHY (DMD)
- ERYTHROPOIESIS STIMULATING AGENTS
- FABRY DISEASE MEDICATIONS
- GENE THERAPY AGENTS
- IMMUNE GLOBULINS
- LANTIDRA (DONISLECEL-JUJU)
- LUTATHERA (LUTETIUM LU 177 DOTATATE)
- LUXTURNA (VORETIGENE NEPARVOVEC-RZYL)
- MEDICAL NECESSITY MEDICATIONS
- MEDICAL STEP THERAPY
- NATALIZUMAB AND NATALIZUMAB BIOSIMILAR
- QALSODY
- RITUXAN AND BIOSIMILARS
- RYSTIGGO (ROZANOLIXIZUMAB-NOLI)
- SANDOSTATIN LAR DEPOT
- YCANTH (CANTHARIDIN)
- ZOLGENSMA (ONASEMNOGENE ABEPARVOVEC-XIOI)
- ZULRESSO
